Kontrol Technologies Corp (KNRLF)

[JohnCM]

GOT IT!

Pfizer vaccination news.


RE:Down of pfizer news
posted November 09, 2020 09:50 am by Jsoull (1)
wilander wrote: Knee jerk reaction. 94K shares traded. Perspective. https://www.cbc.ca/news/health/pfizer-says-early-data-indicates-covid-19-vaccine-is-effective-1...read more

0
someone put a market sell
posted November 09, 2020 09:50 am by mario2007 (15)
and this triggered stop lost. Still very low volume rate and reply

0
Unhalted
posted November 09, 2020 09:49 am by Jsoull (1)
It's dropping fast. Tho TF is dumping shares? rate and reply

0
RE:Omg!!!
posted November 09, 2020 09:46 am by Stormaction (0)
I came here to find out the same thing wtf rate and reply

0
RE:RE:RE:Halted
posted November 09, 2020 09:42 am by Trusted91 (83)
I checked irroc and don’t see a halt. Can someone send me the link rate and reply

0
Down of pfizer news
posted November 09, 2020 09:41 am by wilander (311)
Knee jerk reaction. 94K shares traded. Perspective. rate and reply

0
Chill Folks
posted November 09, 2020 09:41 am by LivingTheDream1 (1858)
The news of the vaccine triggered a panic selling spree which took week hands down. Have a look at the volume traded ......ONLY 100K shares! I expect we will see an update from Paul very shortly and...read more

0
Omg!!!
posted November 09, 2020 09:40 am by Knewbie (119)
What the Fak just happened. ?????! rate and reply

0
RE:RE:Halted
posted November 09, 2020 09:39 am by wilander (311)
Thus far down on a whole 94K shares. ugh. rate and reply

0
RE:Halted
posted November 09, 2020 09:38 am by stevep500 (0)
Yea I'm sure you were trying to buy on -35% drop. whatever the halt is for is obviously not good news rate and reply

1
RE:Halted
posted November 09, 2020 09:37 am by HTNYC1 (125)
Will definitely be a circuit breaker. I managed to pick up another 2300 at $2.05 USD in the panic bargain bucket. rate and reply

0
Halted
posted November 09, 2020 09:35 am by Edcando (92)
Again. Can't see yet if pending news or company contact. Wth happened here this am lol. Was trying to buy on this crazy dip. rate and reply

2
LOL vaccine
posted November 09, 2020 09:30 am by Intrepidor (145)
The markets are going to over-react about the vaccine news, I had to laugh, in the last 2 hrs in went from big hype about the vaccine to just now a headline of' Experts warn of being too optimstic...read more

1
RE:RE:RE:RE:???? 10:00 AM this Morning Major announcement
posted November 09, 2020 09:26 am by wilander (311)
From the Pfizer article: “ Monday's announcement doesn't mean a vaccine is imminent: This interim analysis, from an independent data monitoring board, looked at 94 infections recorded so far...read more

0
KNR is Below the FLOOR - Value = Min 5x Current
posted November 09, 2020 09:24 am by GreatGazoo2 (31)
MCap for 2020 rate and reply

1
RE:RE:RE:???? 10:00 AM this Morning Major announcement
posted November 09, 2020 09:21 am by wilander (311)
I suspect some dummies get out at the open thinking good news on a vaccine is bad for us, which is very short sighted. rate and reply

0
Pfizer vaccine getting close
posted November 09, 2020 09:19 am by wilander (311)
Great news re a vaccine today. But....the most they would have is 25 million doses by year end. And it would still likely not be ready until early next year AND it takes six months to a year...read more

0
RE:RE:???? 10:00 AM this Morning Major announcement
posted November 09, 2020 09:19 am by bobus99 (26)
is this the reason of the low ask price? rate and reply

[JohnCM]

IIROC Trading Halt - KNR

C.KNR | 10 minutes ago
VANCOUVER, BC , Nov. 9, 2020 /CNW/ - The following issues have been halted by IIROC:

Company: Kontrol Energy Corp.

CSE Symbol: KNR

All Issues: Yes

Reason: Single-Stock Circuit Breaker

Halt Time (ET): 9:31:39 AM

IIROC can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and orderly market. IIROC is the national self-regulatory organization which oversees all investment dealers and trading activity on debt and equity marketplaces in Canada .

SOURCE Investment Industry Regulatory Organization of Canada (IIROC) - Halts/Resumptions


Cision View original content: http://www.newswire.ca/en/releases/archive/November2020/09/c3627.html

Canada Newswire
November 9, 2020 - 6:41 AM PST

[JohnCM]

Nowwhat ... what's going on??

[JohnCM]

Need some help this morning. What happened??

[JohnCM]

Posting in U.S.$ when convenient.

[nowwhat2]

Please keep on keeping us informed about this - Wishing U good fortune with them !













128 people on-line - Makes them a pretty hot-topic https://ceo.ca/knr





Hey - Looks like my pullback to 3 bucks DID happen (I remember SEEING that but was expecting a bit more downage)





SHOULD'VE bought that dip (and WOULD'VE if'n it waren't for this) :
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=159327531



Regardless ; Maybe and possibly, should be buying TODAYS' !




Seems to have quite a large spread : bid 4.25 Ask 4.30 ???











PS : Thanks for explaining the Halt !

[The_Free_Nebula]

Interesting...

[JohnCM]

Now we are waiting for UL and Europe??

[Sam Dan]

Finally! THE NEWS WE HAVE BEEN WAITING FOR!
KONTROL RECEIVES CSA STANDARDS APPROVAL FOR BIOCLOUD TECHNOLOGY

Kontrol Energy Corp. has received CSA standards approval for its BioCloud technology.

"This is another important milestone for Kontrol and represents the continuing advancement of the BioCloud technology," says Paul Ghezzi, CEO Kontrol. "CSA is a Canadian standard for safety and is also accepted in jurisdictions outside Canada. In addition to CSA we continue to work on other important regional certifications including UL and CE for the United States and European markets respectively."

Field Certification was provided by ESAFE

CSA regulations require manufacturers of products sold in Canada to receive CSA Standards approval for electrical safety. The field evaluation process follows the CSA's SPE-1000 standard, which has three mandatory and non-destructive tests. Upon successful inspection, ESAFE validates the equipment meets CSA's SPE-1000 standards and labels it approved. ESAFE's labels are recognized across Canada under the Standards Council of Canada accreditation program.

ESAFE is accredited by the Standards Council of Canada (SCC), as an Inspection Body (ISO 17020) and Certification Body (ISO 17065). As an accredited agency, ESAFE is authorized to approve and label equipment for electrical safety.

About Kontrol BioCloud

BioCloud is a real-time analyzer designed to detect airborne viruses. It has been designed to operate as a safe space technology by sampling the air quality over time. With a proprietary detection chamber that can be replaced as needed, viruses are detected, and an alert system is created in the Cloud or over local intranet. BioCloud has been designed for spaces where individuals gather including classrooms, retirement homes, hospitals, mass transportation and others

BioCloud is not a medical device and the Company is not making any express or implied claims that its product has the ability to eliminate, cure or contain the COVID-19 (or SARS-2 Coronavirus).

[JohnCM]

Back on the U.S. OTC Markets.

[JohnCM]

I am set, for now.

[The_Free_Nebula]

I had to snag a few of these shares...

[JohnCM]

https://globalnews.ca/video/7367893/canadian-technology-claims-to-detect-coronavirus-in-air

[JohnCM]

Interesting ...

[Sam Dan]

A month ago I wrote to Investor Relations of Kontrol Energy “Here in Winnipeg I spoke to a friend who is part of the National Research Lab [they discovered the Ebola vaccine]. We talked aboBioCloud Product.He was quite impressed but stated one concern. The cartridge which captures the Covid 19 presents a dangerous product that would have to be shatterproof and successfully destroyed without exposinanyone. Destruction would have to be via a very controlled procedure.
I presume management has remedied that problem but wondered if CSA is the body that would oversee such a requirement and that may be holding up approval.
Just a thought. Any Comment.”

His Response
“CSA covers electrical safety and operation, not the detection chamber

BioCloud is designed with a self cleaning bleach compound for internal cleansing of the device. The detection chamber can be disposed of as biohazard red bag.

Every organization will have their own internal process of cleaning the space as well.

As an interesting fact:

Just think of any hvac filter in a building that has Covid. How are they disposing of those filters? Who comes into contact with those filters?”
I think this illustrates how competent management is in dealing with innovative products.
Patience re CSA, hopefully , that should be cleared soon.

[JohnCM]

Kontrol Receives Approval for Government Grant to Accelerate the Development of New COVID-19 Testing Technology
- Kontrol BioCloud® --

August 5, 2020

Kontrol Energy Corp. (CSE:KNR)(OTCQB:KNRLF)(FSE:1K8) ("Kontrol" or "Company") is pleased to announce that it has received approval for an initial government grant of $50,000 from the National Research Council of Canada to accelerate its new Covid-19 testing technology, the Kontrol BioCloud® analyzer ("BioCloud analyzer" or "BioCloud").

Can we measure for COVID-19 like we do for air quality?

Drawing from its extensive industry experience in air emissions and air quality monitoring, Kontrol is developing a new technology designed to detect and alert for COVID-19, in real-time, through rapid on-site air sampling and detection of aerosol and droplet encapsulated viruses in indoor and outdoor environments.

"Our team has been working to bring BioCloud to market since the onset of COVID-19 and we see a great need for a technology which can provide a level of assurance that spaces where individuals work and congregate can be safe," says Paul Ghezzi, Chief Executive Officer of Kontrol. "If successful, BioCloud will be able to provide pro-active virus detection capabilities with an alert and notification system in public settings and to help maintain confidence as economies re-open."

COVID-19 Testing

The current focus of testing for COVID-19 has been individual swabs. While this remains an important part of the testing regime it would not be possible to test all individuals daily in the cases of large gatherings and transportation.

According to the Center for Disease Control, "the virus that causes COVID-19 is thought to spread mainly from person to person, mainly through respiratory droplets produced when an infected person coughs, sneezes, or talks. These droplets can land in the mouths or noses of people who are nearby or possibly be inhaled into the lungs. COVID-19 seems to be spreading easily and sustainably in the community ("community spread"). Community spread means people have been infected with the virus in an area, including some who are not sure how or where they became infected."

source: www.cdc.gov/coronavirus/2019-ncov/faq.html#Spread

BioCloud has been designed to operate in open spaces where crowds gather or congregate. Through constant air sampling over designated intervals of time and a propriety detection chamber, designed to interact with COVID-19, BioCloud seeks to provide a real-time detection and alert system. BioCloud's anticipated applications include schools, buildings, hospitals, transportation, or any location where crowds are gathered.

"When we initiated the design of BioCloud we leveraged our extensive experience in sampling for low level particulate matter in industrial facilities which includes air quality, emissions and various gases," says Gary Saunders, VP of Kontrol. "We appreciate the government support received to date to accelerate the development of BioCloud."

Development Plan

Kontrol has developed its initial prototype and has commenced lab testing of the detection chamber. The lab will spend the next 4 weeks testing the detection chamber and the applicable interactions with COVID-19. Following the testing period, Kontrol will announce the results and provide further details on its go-to market strategy.

Kontrol is not making any express or implied claims that its BioCloud analyzer has the ability to measure or detect COVID-19 at this time.

[JohnCM]

Kontrol Provides Corporate Update

Moving Forward with Commercialization of BioCloud

September 23, 2020

Kontrol Energy Corp. (CSE:KNR)(OTCQB:KNRLF)(FSE:1K8) ("Kontrol" or "Company") is pleased to provide a corporate update.

"Our team at Kontrol has been very busy since the completion of pre-commercialization testing through the independent labs," says Paul Ghezzi, CEO of Kontrol. "We have now moved to the commercialization phase for the Kontrol BioCloud® analyzer ("BioCloud analyzer" or "BioCloud") which includes further lab testing to establish the lower detection limits.

In addition, we are pleased to share that BioCloud is receiving interest from potential customers and distribution partners and we are selecting key suppliers for commercialization.

We are in discussions with provincial and federal government entities regarding contributions to commercialization funding and potential future procurement. Our internal goal is to have BioCloud units commercially available in November 2020."

Commercialization of BioCloud

As part of BioCloud's commercialization plans, Kontrol will provide lower detection limits and operating specifications for the analyzer. Initial expectations, based on lab testing completed to date, is that BioCloud will be effective in small to medium space settings with 3 or more people, and therefore would be suitable for applications in many environments such as classrooms, offices, airplanes, trains, buses, long-term care facilities and hospitals.

Like all electrical products, BioCloud is required to operate with a CSA approval in Canada. The Company is in the process of seeking CSA approvals as part of commercialization. CSA is a leader in Standards Development and in Testing, Inspection and Certification around the world including Canada, the U.S., Europe and Asia. The CSA registered mark shows that a product has been independently tested and certified to meet recognized standards for safety or performance. The Company has a long history of success in achieving CSA approvals in our established continuous emissions business.

Operating Subsidiaries, Trademarks and Patents

Kontrol BioCloud Inc., which was recently incorporated, is a wholly owned subsidiary of Kontrol, and will be the primary sales and marketing entity for BioCloud. CEM Specialties Inc. ("CEMSI"), also a wholly owned operating subsidiary of Kontrol, will be the primary research, development, and integration entity for BioCloud.

Kontrol has commenced the trademark of the term Safe Space Technology and has initiated the patent registration for its intellectual property related to BioCloud.

Securing Supply Chain

Kontrol has selected a number of suppliers that will form part of BioCloud supply chain, and we will be announcing those names in the coming weeks, following the issuance of applicable purchase orders.

"While we are not making any claims about revenue at this time, we are building our global supply chain with the goal of being able to supply the market with up to 20,000 units per month," says Gary Saunders VP of Kontrol. "We plan to have this substantially completed over the coming weeks."

Strengthened Balance Sheet and Discussions for Additional Government Funding

As of September 22, 2020, the Company has received approximately $1 Million in cash from the exercise of common share options and warrants which has strengthened Kontrol's balance sheet to advance BioCloud's commercialization.

About Kontrol BioCloud

BioCloud is a real-time analyzer designed to detect airborne viruses. It has been designed to operate as a safe space technology by sampling the air quality continuously. With a proprietary detection chamber that can be replaced as needed, viruses are detected, and an alert system is created in the Cloud or over local intranet. BioCloud has been designed for spaces where individuals gather including classrooms, retirement homes, hospitals, mass transportation and others. It can be an important technology which supports the entire system of individual testing and contact tracing.

The Company is not making any express or implied claims that its product has the ability to eliminate, cure or contain the COVID-19 (or SARS-2 Coronavirus).

About Kontrol Energy

Kontrol Energy Corp. (CSE:KNR) (OTCQB:KNRLF) (FSE:1K8) is a leader in the energy efficiency sector through IoT, Cloud and SaaS technology. With a disciplined mergers and acquisition strategy, combined with organic growth, Kontrol Energy Corp. provides market-based energy solutions to our customers designed to reduce their overall cost of energy while providing a corresponding reduction in greenhouse gas (GHG) emissions.

Kontrol Energy is one of Canada's fastest growing companies in 2018 and 2019 as ranked by Canadian Business and Maclean's.

20,000 units per month X $10,000 per unit is annualized revenue of $2,400,000,000

[JohnCM]

OK, so you have a wall unit to test the air. You take this technology and developed a test like a breathalyzer for alcohol. Somehow the mouthpiece etc. would be disposable for each test.

[JohnCM]

They have found a manufacturer, I think.

They say $3M will get the ball rolling.

$10,000 per unit.

I like that they already have revenues.

[Sam Dan]

Many investors have looked at the hospitals, schools, aeroplanes, buses as principal users of KRC's BioCloud devices. While they certainly are candidates, I believe ALL Nursing Homes and Assisted Living complexes are Most important. Based on death statistics these two habitants are the most common sites of contact and death of seniors. There should be MANDATED regulation of all such sites.BioCloud will identify the COVID 19 presence
immediately

[JohnCM]

EDUCATION

David Heinrichs completed his PhD at Queen's University in Kingston, Ontario under the supervision of Dr. Keith Poole investigating iron acquisition in Pseudomonas aeruginosa. He then completed a PDF under the guidance of Dr. Chris Whitfield at the University of Guelph in Guelph, Ontario where he studied lipopolysaccharide biosynthesis and assembly in Escherichia coli. He joined the Faculty in the Department of Microbiology & Immunology at the University of Western Ontario in 1999.

SELECTED HONOURS

2015-2017: Faculty Scholar, University of Western Ontario

2012: Dean’s Award of Excellence, Schulich School of Medicine & Dentistry

2006: Fisher Award, Canadian Society of Microbiologists

2001-2006 : Premier’s Research Excellence Award, Ontario Government

2000-2005 : New Investigator Award, Canadian Institutes of Health Research

https://www.heinrichslab.com/

https://scholar.google.com/citations?user=6QMCzKEAAAAJ&hl=en

[JohnCM]

Kontrol Energy shares fly as its BioCloud technology revealed to detect airborne coronavirus particles

The Canadian company is preparing the technology for applications in schools, hospitals, long term care facilities and mass transit vehicles

Proactive Investors
By Angela Harmantas
12:47 Fri 11 Sep 2020

BioCloud is an unobtrusive wall-mounted technology with a real-time analyzer designed to detect airborne viruses by sampling the air quality over time

Kontrol Energy Corp (CSE:KNR) (OTCQB:KNRLF) saw its stock take off on Friday after the firm revealed its BioCloud technology could detect the presence of coronavirus (COVID-19) in the air.

The Toronto-based firm received positive lab results for BioCloud testing against the live virus that causes COVID-19 following two successful tests against the dormant SARS-CoV-2 virus, it said in a statement.

Shares of Kontrol flew on the news, gaining 62% to reach C$4.86 on the Canadian Securities Exchange and 60.4% over the counter at US$3.60.

BioCloud is an unobtrusive wall-mounted technology with a real-time analyzer designed to detect airborne viruses by sampling the air quality over time. The unit has a proprietary detection chamber that can be replaced as needed if and when viruses are detected. An alert system is created in the cloud or over local intranet.

The Canadian company is preparing the technology for applications in schools, hospitals, long term care facilities and mass transit vehicles, according to a statement.

"There is a critical need for technology that can provide us with assurances that the workplaces, schools, healthcare environments and other spaces we physically occupy are safe and free of infectious disease. Today, we have that in BioCloud," said Paul Ghezzi, Kontrol’s CEO.

"Our team has been working day and night since the onset of the pandemic to bring this exciting technology to market. It will be an invaluable tool to enhance the existing system of individual testing and contact tracing."

Kontrol will start commercializing BioCloud by initiating an application to the CSA Group for independent certification and has already started discussions with two global outsource contract manufacturers who can provide external manufacturing capacity, the company told shareholders.

The unit is expected to cost around US$12,000 based on supply chain components.

Contact Angela at [e-mail]

Follow her on Twitter @AHarmantas

[JohnCM]

Outstanding Shares
34,560,144
09/30/2020

[JohnCM]

Canadian Technology to Detect COVID-19 In The Air

09/11/2020

Canada NewsWire
TORONTO, Sept. 11, 2020

BioCloud Wall Unit Game Changer In Fight To Manage Pandemic

TORONTO, Sept. 11, 2020 /CNW/ - Kontrol Energy Corporation, a Canadian public Company (CSE: KNR) (OTCQB: KNRLF), has launched BioCloud, an unobtrusive wall-mounted technology which detects the presence of COVID-19 in the air and triggers an alert system to provide real time notifications of the pathogen's presence to facility managers, with the aim of allowing outbreaks to be contained before they occur.

Immediate applications in schools, hospitals, long term care facilities and mass transit vehicles including planes, trains and buses represent a game changer in the fight against COVID-19.

"There is a critical need for technology that can provide us with assurances that the workplaces, schools, healthcare environments and other spaces we physically occupy are safe and free of infectious disease. Today, we have that in BioCloud," said Paul Ghezzi, Chief Executive Officer of Kontrol. "Our team has been working day and night since the onset of the pandemic to bring this exciting technology to market. It will be an invaluable tool to enhance the existing system of individual testing and contact tracing."

This breakthrough announcement comes after extensive and independent lab testing in tandem with some of the country's foremost experts in the field, including Dr. David Heinrichs, Professor of Microbiology and Immunology at Western University.

"There's no doubt in my mind that this technology can quickly and effectively detect an array of airborne pathogens, including the virus that causes COVID-19. Our results are absolutely conclusive," confirmed Dr. Heinrichs.

With COVID-19 cases expected to spike across the country this fall and into the winter season, BioCloud commercialization and distribution plans are in high gear.

Gary Saunders, VP of Kontrol, confirms that supply chains for the technology are already prepped to deliver tens of thousands of units monthly.

"We are thrilled to have our hard work validated in the lab with a fully-tested detection chamber that can be moved quickly to market. We anticipate having the first working units in Canadian schools by November of this year," said Saunders. "We're currently on track to have the required manufacturing capability to meet the production volumes of up to 20,000 BioCloud units per month."

With the breakthrough technology coming on the heels of the Federal Government's $2 billion dollar announcement to help schools reopen and operate safely, BioCloud aims to play a vital role in the education sector and beyond.

"We can now detect the virus and assess the effectiveness of HVAC systems by continuously sampling air quality in real-time. As a father and Independent School board member, I understand how this technology can help bring some much needed peace of mind to parents who want to ensure the safety and well being of their kids and loved ones," added Ghezzi. "BioCloud will not just monitor air quality, it seeks to create the conditions for Canadians to safely and confidently return to their jobs and their schools."

Kontrol Energy Corp estimates a $12,000 USD per unit cost for BioCloud based on supply chain components. The detection chamber is fully replaceable after it comes in contact with the SARS-CoV-2 virus and can be disposed of safely and replaced for continuous use.

About Kontrol Energy Corp.

Kontrol Energy Corp., a Candian public company, is a leader in the energy efficiency and air quality sector through IoT, Cloud and SaaS technology. With a disciplined mergers and acquisition strategy, combined with organic growth. Kontrol Energy Corp. provides a combination of software, hardware and service solutions to its customers to improve energy management, air quality and continuous emission monitoring. Kontrol has a client base of blue chip customers spanning the commercial, multi-residential, industrial and institutional building market.

SOURCE Kontrol Energy Corp.

[JohnCM]

Overview

sagecomm is a strategic marketing and communications provider specializing in brand, product and cause positioning, marketing strategy and community engagement.

Our work is rooted in a strategy-first approach, supported by a foundation of market research, audience-focused design, and a high-touch relationship model that treats our clients as partners.

Websitesagecomm.comPhone226-289-2610Phone number is 226-289-2610IndustryMarketing & AdvertisingCompany size11-50 employees8 on LinkedIn
Includes members with current employer listed as sagecomm, including part-time roles.

Headquarters London, Ontario Type Privately Held Founded 2009 Specialties Research and market analysis, marketing strategy, brand positioning, web development, public relations, print and digital design, visual identity development, advertising, corporate communications, and crisis communications

[JohnCM]

How is this possible?

"Kontrol currently has approximately $3.0 Million of cash on hand as of October 28th, 2020 and has sufficient resources to complete the commercialization of BioCloud."

Who stated this?

"It is a given that BioCloud will have the ability to treat subsequent viruses as they occur."

Kontrol establishes lower detection limit for
commercialization of BioCloud

- Kontrol BioCloud a Safe Space Technology -

TORONTO, ON / October 29th, 2020 / Kontrol Energy Corp. (CSE:KNR) (OTCQB:KNRLF)
(FSE:1K8) ("Kontrol" or "Company") is pleased to provide an update on its Kontrol BioCloud
(or "BioCloud") technology. As initially referenced in the press release from September 10,
2020 Kontrol is providing an update on lower detection limits and commercialization.

Lower Detection Limit

"We are pleased to continue to advance towards the production of BioCloud units in
November,” says Paul Ghezzi, CEO Kontrol.

“The lower detection limit is an important
benchmark to provide potential customers with the operating sensitivity of BioCloud.”

As part of its commercialization of the BioCloud technology, Kontrol has currently
established a lower detection limit of 50 SARs-COV-2 virus particles.

This represents a
sufficient sensitivity to the SARS COV-2 virus for commercialization.

The determination of lower detection limit was tested under independent laboratory
conditions over multiple tests.

The BioCloud virus collector was exposed to live SARs-COV2 virus (virus that causes COVID-19) at multiple levels of virus ranging from 10,000, 5,000,
1,000, 100, 50 and 5 viruses.

These tests were conducted multiple times to ensure
repeatability of the response, and under laboratory conditions the detection of the live
SARs-COV-2 virus was repeatably identified at 50 virus particles.

Commercialization

Based on feedback from potential customers and potential distribution channels Kontrol is
seeking multiple certifications concurrently to meet regional requirements.

These include
CSA, CE and UL. CSA is a Canadian certification; CE mainly applies to European electro nic
products and UL is typically required in the USA.

Balance Sheet

Kontrol currently has approximately $3.0 Million of cash on hand as of October 28 th, 2020
and has sufficient resources to complete the commercialization of BioCloud.
National Research Council of Canada
Kontrol has submitted all of its required research and files for potential National Research
Council of Canada funding.
About Kontrol BioCloud
BioCloud is a real-time analyzer designed to detect airborne viruses. It has been designed
to operate as a safe space technology by sampling the air quality over time. With a
proprietary detection chamber that can be replaced as needed, viruses are detected, and
an alert system is created in the Cloud or over local intranet. BioCloud has been designed
for spaces where individuals gather including classrooms, retirement homes, hospitals,
mass transportation and others. It can be an important technology which supports the
entire system of individual testing and contact tracing.
The Company is not making any express or implied claims that its product has the ability
to eliminate, cure or contain the COVID-19 (or SARS-2 Coronavirus).
About Kontrol Energy
Kontrol Energy Corp. (CSE: KNR) (OTCQB: KNRLF) (FSE: 1K8) is a leader in the energy
efficiency sector through IoT, Cloud and SaaS technology. With a disciplined mergers and
acquisition strategy, combined with organic growth, Kontrol Energy Corp. provides marketbased energy solutions to our customers designed to reduce their overall cost of energy
while providing a corresponding reduction in greenhouse gas (GHG) emissions.
Additional information about Kontrol Energy Corp. can be found on its we

[Sam Dan]

While we wait for news re CSA approval management brings
us an important update on the other important features of theBioCloud which includes Sares presence as well as Covid 19. It is a given that BioCloud will have the ability to treat subsequent viruses as they occur.
Meanwhile, management is expanding multiple certifications required.
("Kontrol" or "Company") is pleased to provide an update on its Kontrol BioCloud (or "BioCloud") technology. As initially referenced in the press release from September 10, 2020 Kontrol is providing an update on lower detection limits and commercialization.

Lower Detection Limit

"We are pleased to continue to advance towards production of BioCloud units in November," says Paul Ghezzi, CEO Kontrol. "The lower detection limit is an important benchmark to provide potential customers with the operating sensitivity of BioCloud."

As part of its commercialization of the BioCloud technology, Kontrol has currently established a lower detection limit of 50 SARs-COV-2 virus particles. This represents a sufficient sensitivity to the SARS COV-2 virus for commercialization.

The determination of lower detection limit was tested under independent laboratory conditions over multiple tests. The BioCloud virus collector was exposed to live SARs-COV-2 virus (virus that causes COVID-19) at multiple levels of virus ranging from 10,000, 5,000, 1,000, 100, 50 and 5 viruses. These tests were conducted multiple times to ensure repeatability of the response, and under laboratory conditions the detection of the live SARs-COV-2 virus was repeatably identified at 50 virus particles.

Commercialization

Based on feedback from potential customers and potential distribution channels Kontrol is seeking multiple certifications concurrently to meet regional requirements. These include CSA, CE and UL. CSA is a Canadian certification; CE mainly applies to European electronic products and UL is typically required in the USA.

Balance Sheet

Kontrol currently has approximately $3.0 Million of cash on hand as of October 28th, 2020 and has sufficient resources to complete the commercialization of BioCloud.

National Research Council of Canada

Kontrol has submitted all of its required research and files for potential National Research Council of Canada funding.

About Kontrol BioCloud

BioCloud is a real-time analyzer designed to detect airborne viruses. It has been designed to operate as a safe space technology by sampling the air quality over time. With a proprietary detection chamber that can be replaced as needed, viruses are detected, and an alert system is created in the Cloud or over local intranet. BioCloud has been designed for spaces where individuals gather including classrooms, retirement homes, hospitals, mass transportation and others. It can be an important technology which supports the entire system of individual testing and contact tracing.

The Company is not making any express or implied claims that its product has the ability to eliminate, cure or contain the COVID-19 (or SARS-2 Coronavirus).

About Kontrol Energy

Kontrol Energy Corp. (CSE: KNR) (OTCQB: KNRLF) (FSE: 1K8) is a leader in the energy efficiency sector through IoT, Cloud and SaaS technology. With a disciplined mergers and acquisition strategy, combined with organic growth, Kontrol Energy Corp. provides market-based energy solutions to our customers designed to reduce their overall cost of energy while providing a corresponding reduction in greenhouse gas (GHG) emissions.

[nowwhat2]

He-he-he - It's NOT a fire/smoke alarm !.... but that's an interesting concept !
Everyone RUSH for the exits !....In bedlam !


Please note :

Hey - It's only Day 2 of my learning of this co. so don't mind me if I start asking dumb questions, etc.


Like, how specifically IS and/or WILL they be powered ? By batteries yet, or ? By 120 plug-in ?


So is this a cannabis company turned Covid Hero ?


Thank you for everyone's dd here (I'll start reading)










News seems a little bit sparse (for what's happening), no ? https://www.kontrolenergy.com/investors

Or wait okay this one is better - Or IS it ? https://www.kontrolenergy.com/company-news




PS - Well done in being in on their story so early https://investorshub.advfn.com/boards/read_msg.aspx?message_id=157354978

So they acquired NFA back in MAY ?

[nowwhat2]

Although, sometimes one can't help but wonder.











Good luck........MNXXF

http://ih.advfn.com/stock-market/USOTC/manganese-x-energy-pk-MNXXF/stock-news/83476607/honeywell-detecting-and-cleansing-the-air-of-covi



Kontrol = KNR https://ceo.ca/knr

Holy Doodle Seeker - Wow - You bought into this in MAY ?.....Why, I've just NOW only learned of them !




Hope you're still faring well with all your trading !

[Sam Dan]

Today's Press release shows managment can CHEW Gum as well
as make major developements in their areas of expertize. Encouraging for shareholders.

"("Kontrol" or "Company") is pleased to announce it has won a new order for its smart building technology across four buildings and has been recognized as one of Canada's top growing companies by the Globe and Mail Top Growing Companies 2020.
New Smart Building Technology Win
Following a number of pilots for its SmartSuite® technology the Company has received an order for four apartment buildings located in Ontario, Canada. The contract win was awarded after a comprehensive Request for Proposal (RFP) process that involved other competitors. For industry competitive purposes revenue details and size of the order will not be disclosed.

"We've selected Kontrol and their SmartSuite® technology to help us control, manage and reduce in-suite heating costs in four of our multi-unit residential (apartment) properties in Ontario," says Cam Murchison, Vice President, Property Standards at Q Residential (a leading private real estate asset manager and operator). "Their smart building technology attracted better than expected incentives from the local utility and allows us to understand what is happening within the suites when it comes to temperatures and open windows and doors across the four buildings. With their system providing cloud access to in-suite temperatures and settings, using our mobile devices and laptops, we no longer need to enter our tenant's spaces to troubleshoot and make changes, allowing us to avoid unnecessary and expensive truck rolls. This is a big advantage and benefit under the environment we now operate in."

Globe and Mail Ranks Kontrol 81st in Top 400 Growing Companies

"We arImage: thankful to all of our customers, employees and partners for their support as we continue to develop our technology solutions to build a better future for all," says Paul Ghezzi, CEO of Kontrol Energy.

On September 25th, The Globe and Mail announced its second annual ranking of Canada's Top Growing Companies. The 400 companies cover all industry sectors and were ranked on their three-year revenue growth. Launched in 2019, Canada's Top Growing Companies editorial ranking aims to celebrate entrepreneurial achievement in Canada by identifying and amplifying the success of growth-minded, private and public businesses in Canada. The Globe and Mail refers to the list as "The next generation: the 400 boldest businesses in the country." Kontrol was ranked number 81.

Name Change initiated to Kontrol Technologies Inc.
Following the company's Annual General Meeting on August 28, 2020 the Company has initiated a name change to Kontrol Technologies Inc. from Kontrol Energy Corp. The name change will better reflect the Company's brand and its focus on developing and deploying a comprehensive portfolio of technologies and solutions for smart buildings, smart cities, and safe spaces. The name change will require customary approvals and will take approximately one month to complete.

Update to Prior Press Release
The press release dated August 5th, 2020 is updated to state that CEM Specialties Inc. (CEMSI), a wholly owned operating subsidiary of Kontrol, is in receipt of advisory services and up to $50,000 in research and development funding from National Research Council of Canada Industrial Research Assistance Program (NRC IRAP) to accelerate its new Covid-19 testing technology, the Kontrol BioCloud® analyzer ("BioCloud analyzer" or "BioCloud").

About Kontrol BioCloud
BioCloud is a real-time analyzer designed to detect airborne viruses. It has been designed to operate as a safe space technology by sampling air quality continuously. With a proprietary detection chamber that can be replaced as needed, viruses are detected, and an alert system is created in the Cloud or over local intranet. BioCloud's applications includes classrooms, retirement homes, hospitals, mass transportation and others. BioCloud is currently being developed for commercialization.

[Sam Dan]

Full disclosure from management. Where they are and where they are going!
""Our team at Kontrol has been very busy since the completion of pre-commercialization testing through the independent labs," says Paul Ghezzi, CEO of Kontrol. "We have now moved to the commercialization phase for the Kontrol BioCloudtrademark analyzer ("BioCloud analyzer" or "BioCloud") which includes further lab testing to establish the lower detection limits. In addition, we are pleased to share that BioCloud is receiving interest from potential customers and distribution partners and we are selecting key suppliers for commercialization. We are in discussions with provincial and federal government entities regarding contributions to commercialization funding and potential future procurement. Our internal goal is to have BioCloud units commercially available in November 2020."

Commercialization of BioCloud

As part of BioCloud's commercialization plans, Kontrol will provide lower detection limits and operating specifications for the analyzer. Initial expectations, based on lab testing completed to date, is that BioCloud will be effective in small to medium space settings with 3 or more people, and therefore would be suitable for applications in many environments such as classrooms, offices, airplanes, trains, buses, long-term care facilities and hospitals.

Like all electrical products, BioCloud is required to operate with a CSA approval in Canada. The Company is in the process of seeking CSA approvals as part of commercialization. CSA is a leader in Standards Development and in Testing, Inspection and Certification around the world including Canada, the U.S., Europe and Asia. The CSA registered mark shows that a product has been independently tested and certified to meet recognized standards for safety or performance. The Company has a long history of success in achieving CSA approvals in our established continuous emissions business.

Operating Subsidiaries, Trademarks and Patents

Kontrol BioCloud Inc., which was recently incorporated, is a wholly owned subsidiary of Kontrol, and will be the primary sales and marketing entity for BioCloud. CEM Specialties Inc. ("CEMSI"), also a wholly owned operating subsidiary of Kontrol, will be the primary research, development, and integration entity for BioCloud.

Kontrol has commenced the trademark of the term Safe Space Technology and has initiated the patent registration for its intellectual property related to BioCloud.

Securing Supply Chain

Kontrol has selected a number of suppliers that will form part of BioCloud supply chain, and we will be announcing those names in the coming weeks, following the issuance of applicable purchase orders.

"While we are not making any claims about revenue at this time, we are building our global supply chain with the goal of being able to supply the market with up to 20,000 units per month," says Gary Saunders VP of Kontrol. "We plan to have this substantially completed over the coming weeks."

Strengthened Balance Sheet and Discussions for Additional Government Funding

As of September 22, 2020, the Company has received approximately $1 Million in cash from the exercise of common share options and warrants which has strengthened Kontrol's balance sheet to advance BioCloud's commercialization.

About Kontrol BioCloud

BioCloud is a real-time analyzer designed to detect airborne viruses. It has been designed to operate as a safe space technology by sampling the air quality continuously. With a proprietary detection chamber that can be replaced as needed, viruses are detected, and an alert system is created in the Cloud or over local intranet. BioCloud has been designed for spaces where individuals gather including classrooms, retirement homes, hospitals, mass transportation and others. It can be an important technology which supports the entire system of individual testing and contact tracing.

The Company is not making any express or implied claims that its product has the ability to eliminate, cure or contain the COVID-19 (or SARS-2 Coronavirus)."

[Sam Dan]

2 MATTERS TO DISCUSS RE KNR
Most people probably were unaware that the EBOLA vaccine was developed in Winnipeg, Canada at the Federal laboratory. Due to political pressure, the FDA approval required it to be rleased from a small company in USA so they could take the credit. I mention that because a had a friend who was part of the Canadian team. She is now in Britain as they develop a vaccine for COVVID19 and I have talked to her re the BioCloud of KNR.
She is very impressed with this development, particularly [and I am not sure why] the fact that they can “recognize” the COVID 19 virus and MOST important, that management says they have the ability to use this method for Any virus, fungi,or bacteria. Eventually, there will be a working vaccine for COVID 19 but that doesn’t make the BioCloud device obsolete. Animal to human transmissions are going to happen more often and the BioCFloud will be a major weapon in containment. My friend asked me to ask a few questions but the Investor Relations contact is too busy to respond.
Listening to Question Period [Canadian News program] today, they stated the major problem right now is the lack of ‘instant’ testing ability for the COVID 19 virus as we face the coming Flu season. That.s were BioCloud will help solve the problem!! The federal government and Provinces will be dealing with expenditures to fight the battles, so, hopefully, we will see contracts signed in the coming weeks.

[lukin4winners]

MM's will try and shake some out after yesterdays blistering highs based on their COVID 19 ability to detect pathogens to keep schools and public places safe from the virus.

Canadian Technology to Detect COVID-19 In The Air
Canada NewsWire

TORONTO, Sept. 11, 2020

BioCloud Wall Unit Game Changer In Fight To Manage Pandemic

TORONTO, Sept. 11, 2020 /CNW/ - Kontrol Energy Corporation, a Canadian public Company (CSE: KNR) (OTCQB: KNRLF), has launched BioCloud, an unobtrusive wall-mounted technology which detects the presence of COVID-19 in the air and triggers an alert system to provide real time notifications of the pathogen's presence to facility managers, with the aim of allowing outbreaks to be contained before they occur.

Immediate applications in schools, hospitals, long term care facilities and mass transit vehicles including planes, trains and buses represent a game changer in the fight against COVID-19.

"There is a critical need for technology that can provide us with assurances that the workplaces, schools, healthcare environments and other spaces we physically occupy are safe and free of infectious disease. Today, we have that in BioCloud," said Paul Ghezzi, Chief Executive Officer of Kontrol. "Our team has been working day and night since the onset of the pandemic to bring this exciting technology to market. It will be an invaluable tool to enhance the existing system of individual testing and contact tracing."

This breakthrough announcement comes after extensive and independent lab testing in tandem with some of the country's foremost experts in the field, including Dr. David Heinrichs, Professor of Microbiology and Immunology at Western University.

"There's no doubt in my mind that this technology can quickly and effectively detect an array of airborne pathogens, including the virus that causes COVID-19. Our results are absolutely conclusive," confirmed Dr. Heinrichs.

With COVID-19 cases expected to spike across the country this fall and into the winter season, BioCloud commercialization and distribution plans are in high gear.

Gary Saunders, VP of Kontrol, confirms that supply chains for the technology are already prepped to deliver tens of thousands of units monthly.

"We are thrilled to have our hard work validated in the lab with a fully-tested detection chamber that can be moved quickly to market. We anticipate having the first working units in Canadian schools by November of this year," said Saunders. "We're currently on track to have the required manufacturing capability to meet the production volumes of up to 20,000 BioCloud units per month."

With the breakthrough technology coming on the heels of the Federal Government's $2 billion dollar announcement to help schools reopen and operate safely, BioCloud aims to play a vital role in the education sector and beyond.

"We can now detect the virus and assess the effectiveness of HVAC systems by continuously sampling air quality in real-time. As a father and Independent School board member, I understand how this technology can help bring some much needed peace of mind to parents who want to ensure the safety and well being of their kids and loved ones," added Ghezzi. "BioCloud will not just monitor air quality, it seeks to create the conditions for Canadians to safely and confidently return to their jobs and their schools."

Kontrol Energy Corp estimates a $12,000 USD per unit cost for BioCloud based on supply chain components. The detection chamber is fully replaceable after it comes in contact with the SARS-CoV-2 virus and can be disposed of safely and replaced for continuous use.

[Sam Dan]

CORRECTION!!
I entered the wrong amount charged for a change in the detection chamber
it should read $300.00us X 4= 1.200.00 per year minimum
Sorry

[Sam Dan]

I have been informed that the detection chamber of the BioCloud which holds the found COVID 19 would have to be changed about every three months or when the COVID was detected, whichever came earlier.
This means at a minimum [ie no COVID found] there would be an $800.00 X 4=$3200.00per year revenue stream for each installation.
Obviously once the pandemic has been hopefully eliminated, BioCloud would remain in position for any subsequent noxious element, with the chamber empty..

[TrendTrade2016]

KNR.CA freaking monster...if this works...a true life changer!!

[Sam Dan]

I have been asked by a number of shareholders to repost what I wrote yesterday. As well, I want to clarify how the BioCloud device registers the presence of the COVID19. It is NOT a fire Alarm!
The device when it detects Covid-19 can send the alert over wifi that Covid has been detected to the proper authorities. A principal of a school, a pilot in a plane, or management of an office.
No sound and the alert is digital. It's not designed to cause a panic but to notify so that the appropriate actions can then be taken.

[Sam Dan]

I have been doing DD on Kontrol Energy’s BioCloud Project using contacts in the medical, technology and financial sectors. As a shareholder, I believe we have a possible huge opportunity of success as they develop the BioCloud role in maintaining control of the Covid 19 virus.
First, we have a Patented/ pending Patent product that has a unique ability to capture and isolate the covid19 virus and giving instant notice of its presents in the vicinity. Thus, isolation and mitigation efforts can save lives by avoiding contagion and seeking early treatment for carriers.
It should be noted that this technique would NOT be isolated to covid 19. Management is confident any subsequent viruses could be identified.
As quoted in the company's release “Dr. David Heinrichs’, Ph.D technology will allow for the measurement of many different viruses, bacteria, and fungi beyond the immediate need for the virus that causes COVID-19.”
Believe me, there will be more such epidemics- not 1 every hundred years but, due to modern travel and open borders, the rapid spread of viruses will be the norm. And, in a dark realism, deliberate spreads may become a reality.
The BioCloud unit can cover approximately 3-4 thousand square feet, depending on wall positioning. Thus classrooms, offices, condos, apartments, homes, buses, planes, hospitals etc, etc can be covered logically.
The cost of $12,000.00 per unit seems quite reasonable and Kontrol Energy Corp should receive significant revenue. But the disposal of the captured virus must be disposed on a regular basis. It will be recommended that a positive captured virus in the detection chamber demands easy removal of the chamber and disposal and insertion of a sterile detection chamber. Such a chamber would have a cost of approx. $300.00 [all funds in us]
Thus significant recurring revenue for the company.
Management at the webcast stated they feel the company has a leadership position with BioCloud and are carefully moving forward to maintain their position.
Commercialization
“Kontrol will begin the commercialization process of BioCloud by initiating an application to the CSA Group. CSA is a leader in Standards Development and in Testing, Inspection and Certification around the world including Canada, the U.S., Europe and Asia. The CSA registered mark shows that a product has been independently tested and certified to meet recognized standards for safety or performance. Kontrol anticipates that a CSA approval can take from 30 to 45 days to complete and Kontrol has a history of working with CSA on various air quality and emission products. During the process of CSA approval, Kontrol will seek to establish lower detection limits of the COVID-19 virus. Lower detection limit specifications are part of the commercial specifications that Kontrol will deliver for a fully commercialized product. The fact that the company has applied for approval on other matters gives them hope 4-6 weeks will see approval.
They are talking to the Canadian Federal government and Provincial governments specifically for school sites. As I have previously stated, a contract with either entity would be warmly accepted by banks as collateral for loans, so that costs of BioCloud production should not entail needs for share dilution by a PP.
Once the Canadian rollout is completed there was indications from the webcast that at least 2 parties in Europe were interested. Then, of course, the world comes a calling. And probably a MAJOR company may take a look.
All enticing, I would suggest watching. It may be the Canadian play of
this year and next!!






































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































this year and the next!!

[Sam Dan]

AND AWAY WE GO!! Management has obviously planned ahead
KONTROL'S COVID-19 TECHNOLOGY RECEIVES POSITIVE LAB RESULTS FOR LIVE COVID-19 TESTING

Kontrol Energy Corp. has provided an update on its Kontrol BioCloud technology.

Lab Testing with Live Virus

Kontrol has received positive lab results for BioCloud testing against the live virus that causes COVID-19. This positive result follows two successful tests against the dormant SARS-CoV-2 virus (see press release dated August 10th, 2020 and press release dated August 27th, 2020).

"We are very pleased that through a methodical approach we have been able to successfully test our technology with the live virus causing COVID-19 and will turn our focus to commercialization of BioCloud," says Paul Ghezzi, CEO of Kontrol. "It has been a long journey to get to this point since the initial concept design in March 2020 and through the great efforts of our team we look forward to delivering a safe space technology solution.""This technology can improve our surveillance of SARS-CoV-2 by monitoring air quality inmultiple settings."Dr. Jimmy D. Dikeakos, Ph.D"This technology will allow for measurement of many different viruses, bacteria, and fungi beyond the immediate need for the virus that causes COVID-19."Dr. David Heinrichs, Ph.D

Commercialization

Kontrol will begin the commercialization process of BioCloud by initiating an application to the CSA Group. CSA is a leader in Standards Development and in Testing, Inspection and Certification around the world including Canada, the U.S., Europe and Asia. The CSA registered mark shows that a product has been independently tested and certified to meet recognized standards for safety or performance. Kontrol anticipates that a CSA approval can take from 30 to 45 days to complete and Kontrol has a history of working with CSA on various air quality and emission products. During the process of CSA approval, Kontrol will seek to establish lower detection limits of the COVID-19 virus. Lower detection limit specifications are part of the commercial specifications that Kontrol will deliver for a fully commercialized product.

"We are very pleased to start the process of sharing our technology with the market through the commencement of commercialization," says Gary Saunders, VP of Kontrol. "We want to thank our lab partners for all of their expertise and dedication. The lab procedures involved significant planning and preparation to execute meticulous testing against the live COVID-19 virus. We look forward to sharing our results with all levels of Government in the coming days and weeks ahead."

Manufacturing Capacity

Kontrol has commenced discussions with two global outsource contract manufacturers who can provide Kontrol with external manufacturing capacity. Kontrol is not making any statements or assumptions about potential revenues, however, Kontrol is planning for up to 20,000 BioCloud units per month as manufacturing capacity. This is part of Kontrol's prudent overall planning and access to manufacturing capability.

About Kontrol BioCloud

BioCloud is a real-time analyzer designed to detect airborne viruses. It has been designed to operate as a safe space technology by sampling the air quality over time. With a proprietary detection chamber that can be replaced as needed, viruses are detected, and an alert system is created in the Cloud or over local intranet. BioCloud has been designed for spaces where individuals gather including classrooms, retirement homes, hospitals, mass transportation and others. It can be an important technology which supports the entire system of individual testing and contact tracing.

The Company is not making any express or implied claims that its product has the ability to eliminate, cure or contain the COVID-19 (or SARS-2 Coronavirus).

About Kontrol Energy

Kontrol Energy Corp. (CSE: KNR) (OTCQB: KNRLF) (FSE: 1K8) is a leader in the energy efficiency sector through IoT, Cloud and SaaS technology. With a disciplined mergers and acquisition strategy, combined with organic growth, Kontrol Energy Corp. provides market-based energy solutions to our customers designed to reduce their overall cost of energy while providing a corresponding reduction in greenhouse gas (GHG) emissions.

[Dmitri/Canada]

This will be between 20-30 very soon

[Sam Dan]

The conference call with management was exceedingly informative!
My 2 ancillary questions . 1. was answered. The system does not send an "alarm" signal but can be read from the unit so no 'fear' alarm. 2. removal of the collected virus safely is still being studied.
To me, the most important information is that this BioCloud unit can be used for ANY noxious virus now or in the virus of the future. This means the units are not of limited usage. A tremendous selling feature.
Management in answering other questions showed a high level of intelligent concern that development is not so rushed that would cause problems in the future. Safety of Product. Protection of patent calls for proper rollout. Right now Canadian Federal and Provincial roll out will be the prime target area. Once established indicated interest from Europe and USA would be considered. Management considers they have a lead in the Marketplace that allows them to maintain a high level of development. IMO RIGHTLY SO!

[BiotechinvestorRLF]

Hello Sam Dan
What is you current price Target for Kontrol...I see a fair valuation of 300 M US per 2021
God bless

[Sam Dan]

Just an observation from a long time shareholder. KNR traded
over the mid $2.00, 2 or 3 years ago with nowhere near the quality of their platforms and abilities they now have!
I have 3 questions I hope to get answered today. If the answers are positive , we have a HUGE future ahead. If not, the company warrants the pricing we are achieving now.Just MO

[BiotechinvestorRLF]

Top Pick Sept 2020

[BiotechinvestorRLF]

yes agee a STRONG BUY! Top pick Sept 2020 US Momentum Traders

[BiotechinvestorRLF]

COVID-19 breaktrue with BIOCLOUD next!

Kontrol Receives Approval for Government Grant to Accelerate the Development of New COVID-19 Testing Technology
August 5, 2020
-- Kontrol BioCloud® --

TORONTO, ON / ACCESSWIRE / August 5, 2020 / Kontrol Energy Corp. (CSE:KNR)(OTCQB:KNRLF)(FSE:1K8) ("Kontrol" or "Company") is pleased to announce that it has received approval for an initial government grant of $50,000 from the National Research Council of Canada to accelerate its new Covid-19 testing technology, the Kontrol BioCloud® analyzer ("BioCloud analyzer" or "BioCloud").

Can we measure for COVID-19 like we do for air quality?

Drawing from its extensive industry experience in air emissions and air quality monitoring, Kontrol is developing a new technology designed to detect and alert for COVID-19, in real-time, through rapid on-site air sampling and detection of aerosol and droplet encapsulated viruses in indoor and outdoor environments.

[BiotechinvestorRLF]

Buy Alert from US Momentum Trader Channel
Just saw the video amazing

[BiotechinvestorRLF]

Real Time Covid-19 Virus Scanner Biocloud...Multibillion Dollar New Market

When I see other Covid 19 Stocks in my Portfolio, this Kontrol Energy is a 10x bagger easy

[Sam Dan]

Great news today. Trading starts tomorrow morning
This should be a major revenue source for EVER not just for Covoid
" KONTROL'S COVID-19 TECHNOLOGY PROTOTYPE RECEIVES POSITIVE LAB TEST RESULTS

Kontrol Energy Corp.'s Kontrol BioCloud fully functioning prototype was able to operate in real-time and has received positive lab test results.

"Following lab testing, we have demonstrated that our fully operating prototype, previously announced on August 10, 2020, can detect COVID-19 specific components in air samples under a controlled experiment," says Paul Ghezzi, Chief Executive Officer of Kontrol. "This was a critical milestone that we achieved as it ensures the safety and operating capability of BioCloud and we can now move quickly to testing against the live aerosolized COVID-19 virus. We remain on track with achieving our specific milestones and anticipate live COVID-19 virus testing during the week of August 31."

The controlled testing was conducted by the lab of independent consultant, Dr. David Heinrichs, PhD (Heinrichs Laboratory) - experts in the study of Microbiology and Immunology.

Next Major Milestones

The company has now tested both its proprietary detection chamber as announced on August 19, 2020 and its fully operating prototype. Following testing with the live COVID-19 virus, the Company anticipates that it will be in a position to move to commercialization and production of operating units shortly thereafter.

We continue to fund all BioCloud technology development through internal cash generation and Kontrol will not raise capital to complete testing and pre-commercialization work.

When testing against the live COVID-19 virus the Company seeks to establish the lower detection limits of BioCloud and set final parameters for applications based on room size and number of individuals. These lower detection limits will be part of commercialization specifications.

Commercialization Plans

"We are excited to have a working prototype and a successful result given all the hard work that has gone into the BioCloud," says Gary Saunders VP of Kontrol. "We have sourced all the components required for commercialization and have our supply chain ready to go. The Canadian Government has recently announced $2 billion in federal funding to help schools reopen safely. BioCloud has the potential to be an important tool in creating safe spaces by seeking to detect for the virus and assessing the effectiveness of HVAC system improvements by continuously sampling air in real-time."

The Company anticipates a selling price in the range of $12,000 US per BioCloud unit based on the current supply chain components. The detection chamber is replaceable and represents a potential secondary source of commercialized revenue for Kontrol. Any time the detection chamber comes into contact with the COVID virus it must be disposed of safely and replaced.

New Applications beyond COVID-19

During testing the Company has determined that BioCloud has the capability to detect other airborne viruses in addition to COVID-19. This determination was made based on working with the independent lab consultants and a review of the detection mechanism and specifications. While COVID-19 is the most pressing concern for creating safe spaces, other airborne viruses may have similar characteristics that BioCloud may be able to detect.

About Kontrol BioCloud

BioCloud is a real-time analyzer designed to detect airborne viruses. It has been designed to operate as a safe space technology by sampling the air quality over time. With a proprietary detection chamber that can be replaced as needed, viruses are detected, and an alert system is created in the Cloud or over local intranet. BioCloud has been designed for spaces where individuals gather including classrooms, retirement homes, hospitals, mass transportation and others. It can be an important technology which supports the entire system of individual testing and contact tracing.

The Company is not making any express or implied claims that its product has the ability to eliminate, cure or contain the COVID-19 (or SARS-2 Coronavirus) at this time."

[Sam Dan]

Update from management re KontrolBiocloud analyzer plans.
Of special interest is "developed a proprietary COVID-19 detection chamber." [ie patent protected}
and "AT THIS TIME" no claim of cure, etc.leaves the future open?

("Kontrol" or "Company") is pleased to provide an update on the timing of the next stage of testing for the Kontrol BioCloud® analyzer ("BioCloud").

For more than a decade, through its operating subsidiaries, Kontrol has been providing air quality testing and continuous emission monitoring across hundreds of industrial facilities in Canada and the USA. BioCloud represents an extension and further innovation of an existing air quality technology and solution platform which Kontrol currently provides to its customers.

"We are drawing on our extensive experience in air quality and emission monitoring for specific particulate analysis and measurement and using similar technology to detect for COVID-19 in the air," says Paul Ghezzi, CEO of Kontrol. "Over the past 6 months, we have secured government funding, established partnerships with virology experts, and developed a proprietary COVID-19 detection chamber. Our initial lab results and interest from potential customers and prospects give us the confidence that we are developing a solution which the market demands. We look forward to providing more details as we continue BioCloud's development."

Next Stage of Testing

Live COVID-19 virus testing will commence on August 19th, 2020 and is expected to continue until the end of the month. The testing will focus on the capability of the working BioCloud prototype to sample the COVID-19 virus in aerosol form and seek to establish the lower detection limits that can be achieved. Kontrol will publish the results following the testing.

Detection Mechanism

Kontrol has designed BioCloud with a replaceable detection mechanism. Kontrol will seek to patent the detection mechanism following the next stage of testing. Kontrol will also analyze the best method of replacing and disposing of the detection mechanism after it comes into contact with COVID-19. The detection mechanism has been built to be an ongoing replaceable component of the BioCloud technology.

"BioCloud will seek to sample the air over-time on a continuous basis, which is similar to how we currently test for air quality in industrial facilities. Applications for BioCloud will be focused initially on classrooms, hospitals, long-term care homes, and mass transportation." said Gary Saunders, Kontrol's Vice President.

Pre-Commercialization Prototypes

Kontrol has built one operating prototype and is in the process of completing four additional pre-commercialization prototypes. These prototypes will be made available for lab testing and also provide Kontrol with greater certainty for developing its supply chain for parts and materials for potential future commercialization. The additional four prototypes will be completed prior to August 31st, 2020.

The Company is not making any express or implied claims that its product has the ability to eliminate, cure or contain the Covid-19 (or SARS-2 Coronavirus) at this time.